nPhase Raises $30M Series D for Clinical Data Platform

In 2019, nPhase was already extending its collection software into analytics and warehousing across research studies. Seven years later, the company is asking pharmaceutical sponsors to give it responsibility for a much longer stretch of the clinical-data journey, including the work that turns study records into a submission package. That progression gives its latest financing a commercial history beyond the arrival of another AI product.

nPhase announced a $30M Series D led by Viking Global Investors on November 2, 2026. The Atlantic Beach, Florida company says the round is its first equity financing since 2017 and will expand its enterprise business and agentic AI capabilities. Its proposition brings data management and statistical computing closer together, giving sponsors a broader software relationship to evaluate as they prepare clinical evidence for regulatory review.

What the Series D expands

The financing follows the September launch of nPhase.ai, which connects the company's Unified Data Management System, or UDMS, and Statistical Computing Environment, or SCE. Data from research sites, laboratories, patients and sensors enters the management layer; the computing environment carries the work toward analysis and submission outputs. The intended purchase reaches across activities that a sponsor may otherwise coordinate through separate systems and teams.

Viking Global Investors is the named lead investor. nPhase has not disclosed a valuation, a complete list of participating investors or an allocation of the proceeds among its products. The company identifies enterprise expansion and additional agentic capabilities as priorities, rather than providing a numerical hiring plan or a country-by-country rollout schedule.

The long interval since the company's previous equity raise matters because this financing backs an expanding operating business with a product history. It also leaves important capital-accounting boundaries intact: a statement about equity raises says nothing definitive about profitability, debt or every other source of funding. The $30M headline can stand on its own without being inflated into a financial biography the announcement does not provide.

For CEO Scott Climes and CTO Jaya Prakash Rao, the broader assignment brings more of the sponsor's working process inside the product discussion. A collection tool can earn a place with the team capturing records. A platform reaching toward submission must also make sense to the people transforming, reviewing and explaining those records later.

From data capture to statistical work

The company behind nPhase.ai also operates REDCap Cloud. A February 2016 Vanderbilt report documented the licensing relationship that brought a hosted commercial version of Vanderbilt's REDCap technology to market. That academic origin explains one part of the company's route into research software without turning the university's work into an invented startup founding story.

By September 2019, nPhase was describing Business Intelligence Studio, an analytics and warehousing product that could aggregate information across research studies. The release described client work on integration, transformation and enrichment. Collection was already becoming the beginning of a longer commercial relationship with the data.

The current UDMS product description extends that trajectory through unified acquisition, standardization and validation. SCE addresses the statistical work that follows, bringing programming and submission preparation into the wider platform. The connection matters because the team explaining an analysis needs to understand how the inputs reached it, including the transformations made along the way.

That continuity is part of what the supplier is asking a customer to buy. A sponsor evaluating an integrated platform has to examine whether information and its history remain understandable as responsibility moves among data managers, programmers and reviewers. Combining products expands the scope of that conversation; the commercial value depends on how well the combined workflow fits the sponsor's actual operating arrangements.

The reviewer stays in the workflow

nPhase's SCE demonstration describes a sequence in which AI proposes transformations, humans approve them and deterministic engines execute them. The company also describes versioned computational environments and traceable inputs and outputs. Human review is an explicit part of the architecture being sold to sponsors.

That design gives buyers something more concrete to examine than a general promise of autonomous work. Who can approve a transformation, which version was used, and how a result can be reproduced all belong in the purchasing conversation. A demonstration can show the route through those decisions, while an implementation has to accommodate the customer's teams, procedures and study requirements.

In its September platform announcement, nPhase said SCE could reduce a preparation process normally lasting four or more months to weeks. That remains a company performance claim. A sponsor assessing it would need to understand the studies, starting conditions and review work behind the comparison before building its own operating calendar around the number.

Faster preparation and a clear review record have to coexist in the same purchase. The customer remains responsible for the evidence moving toward a submission, even when software performs more of the work. The practical appeal of the platform therefore reaches into the time reviewers spend understanding what happened, as well as the time programmers spend producing the next output.

DevCuration's coverage of Intake AI's clinical-trial agents and Mithrl's biopharma research infrastructure examines adjacent parts of the research workflow. Those companies have different assignments, providing context for how many separate decisions sit inside the broad label of AI for life sciences.

A broader supplier relationship

nPhase's current leadership page identifies Climes as CEO, Rao as CTO, Dave Sunderhaft as COO and Mark Lama as CFO. That same company source reports a REDCap Cloud footprint of more than 500 clients. Those existing-business figures provide context for the supplier's history; they should be kept separate from adoption or performance claims about the newer SCE offering.

The Series D finances a wider mandate inside an account. Data collection, management and statistical preparation involve different work, yet the sponsor needs a coherent record connecting them. An integrated supplier has an opportunity to reduce the number of handoffs the customer must coordinate, while accepting a larger role in keeping that record usable.

For buyers, that makes the boundary of responsibility a useful place to begin a conversation with nPhase. The product demonstration, implementation plan and review procedures need to describe the same journey through the study. As Climes and Rao expand the platform with Viking's backing, the continuing relationship will include the people who have to explain each transformation when the submission package reaches their desk.